Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112931
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2005-06-02
Brief Title:
Rituximab in Treating Patients With Newly Diagnosed Stage II Stage III or Stage IV Follicular Non-Hodgkins Lymphoma
Sponsor:
University College London
Organization:
University College London
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| stage III grade 1 follicular lymphoma | View |
| stage III grade 2 follicular lymphoma | View |
| stage III grade 3 follicular lymphoma | View |
| stage IV grade 1 follicular lymphoma | View |
| stage IV grade 2 follicular lymphoma | View |
| stage IV grade 3 follicular lymphoma | View |
| noncontiguous stage II grade 1 follicular lymphoma | View |
| noncontiguous stage II grade 2 follicular lymphoma | View |
| noncontiguous stage II grade 3 follicular lymphoma | View |
| contiguous stage II grade 1 follicular lymphoma | View |
| contiguous stage II grade 2 follicular lymphoma | View |
| contiguous stage II grade 3 follicular lymphoma | View |